Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)

  • ID: 4410338
  • Drug Pipelines
  • Region: Global
  • 90 Pages
  • Koncept Analytics
1 of 6
Chronic Ailments and Infectious Diseases to Drive IVD Market

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Roche Holding AG
  • Siemens AG
  • MORE

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient’s body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. Purpose for doing the IVD test is to prevent, effectively cure and mitigate any kind of risk and for post-treatment intensive care diseases and infections. IVD products are precisely designed and produced for collecting samples derived from the human body and scrutinizing them outside the human body.

The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into various sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test.

Growth of the global IVD market is driven by several factors including rapid occurrence of infectious diseases, increasing diabetic patient base, and surge in incidences of chronic ailments. Further, growing geriatric population, rising GDP per capita and increasing healthcare expenditure per capita will act as a catalyst for market growth. Owing to the suitable demographical changes and rising disposable income coupled with improving basic infrastructure, developing regions such as Asia-Pacific and Latin America are expected to experience robust growth. However, the market growth prospects could be hindered by lack of customer adoption, lack of proper facilities and infrastructure and strict government regulations.

The report "Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)" analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Roche Holding AG
  • Siemens AG
  • MORE

1. Overview
1.1 In-Vitro Diagnostics (IVD)
1.2 IVD Product by Types
1.3 IVD Tests
1.4 IVD Market by Technology
1.5 IVD Uses
1.6 IVD Value Chain Analysis

2. Global IVD Market
2.1 Global IVD Market by Value
2.2 Global IVD Market Forecast by Value
2.3 Global IVD Market by Region
2.4 Global IVD Market by Indications
2.5 Global IVD Market by Test Location
2.6 Global IVD Market by Product
2.6.1 Global IVD Reagents Market Forecast by Value
2.6.2 Global IVD Instrument Market Forecast by Value
2.7 Global IVD Market by Technology

3. Global IVD Market Analysis by Technology
3.1 Global SMBG Market Forecast by Value
3.2 Global Clinical Chemistry Market Forecast by Value
3.3 Global Immunochemistry Market
3.3.1 Global Immunochemistry Market Forecast by Value
3.3.2 Global Immunochemistry Market by Indications
3.4 Global Molecular Diagnostics Market
3.4.1 Global Molecular Diagnostics Market Forecast by Value
3.4.2 Global Molecular Diagnostics Market by Indications
3.4.3 Global Molecular Diagnostics Market by Regions
3.5 Global Point Of Care (POC) Market Forecast by Value
3.6 Global Microbiology Market
3.6.1 Global Microbiology Market Forecast by Value
3.6.2 Global Microbiology Market by Indication
3.7 Global Hematology Market Forecast by Value

4. Regional IVD Market
4.1 North America
4.1.1 North America IVD Market Forecast by Value
4.1.2 North America Microbiology Market by Indication
4.1.3 The US IVD Market Forecast by Value
4.2 EMEA
4.2.1 EMEA IVD Market Forecast by Value
4.2.2 Europe Microbiology Market by Indications
4.3 Asia-Pacific
4.3.1 Asia-Pacific IVD Market Forecast by Value
4.3.2 China IVD Market Forecast by Value
4.3.3 Japan IVD Market Forecast by Value
4.4 Latin America
4.4.1 Latin America IVD Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Diabetic Patient Base
5.1.2 Rapid Occurrence of Infectious Diseases
5.1.3 Surge in Incidences of Chronic Ailments
5.1.4 Increasing Global Healthcare Expenditure Per Capita
5.1.5 Rising Global GDP per Capita
5.1.6 Growing Geriatric Population
5.2 Key Trends & Developments
5.2.1 Rise in CFDA IVD Market Approvals
5.2.2 Consolidation of Core Labs
5.2.3 Increasing Penetration of the US LDT Companies in European IVD Market
5.2.4 Mergers & Acquisitions
5.3 Challenges
5.3.1 Lack of Customer Adoption
5.3.2 Urgent Need for Proper Infrastructure
5.3.3 Government Regulation for IVD Tests

6. Competitive Landscape
6.1 Global IVD Market
6.1.1 Revenue and Market Cap. Comparison
6.1.2 Global IVD Market Share by Company
6.1.3 Global Immunochemistry Market Share by Company
6.1.4 Global Molecular Diagnostics Market Share by Company
6.1.5 Global POCT Market Share by Company

7. Company Profiles
7.1 Siemens AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Roche Holding AG
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Abbott Laboratories
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Danaher Corporation
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies

List of Figures

  • Types of Diagnostics
  • Types of IVD Products
  • Types of IVD Tests
  • IVD Market by Technology
  • IVD Value Chain Analysis
  • Global IVD Market by Value (2012-2016)
  • Global IVD Market Forecast by Value (2017-2021)
  • Global IVD Market by Region (2016)
  • Global IVD Market by Indications (2016)
  • Global IVD Market by Test Location (2016)
  • Global IVD Market by Product (2016)
  • Global IVD Reagents Market Forecast by Value (2016-2021)
  • Global IVD Instrument Market Forecast by Value (2016-2021)
  • Global IVD Market by Technology (2016)
  • Global SMBG Market Forecast by Value (2016-2021)
  • Global Clinical Chemistry Market Forecast by Value (2016-2021)
  • Global Immunochemistry Market Forecast by Value (2016-2021)
  • Global Immunochemistry Market by Indications (2016)
  • Global Molecular Diagnostics Market Forecast by Value (2016-2021)
  • Global Molecular Diagnostics Market by Indications (2016)
  • Global Molecular Diagnostics Market by Regions (2016)
  • Global Point Of Care (POC) Market Forecast by Value (2016-2021)
  • Global Microbiology Market Forecast by Value (2016-2021)
  • Global Microbiology Market by Indication (2016)
  • Global Hematology Market Forecast by Value (2016-2021)
  • North America IVD Market Forecast by Value (2016-2021)
  • North America Microbiology Market by Indication (2016)
  • The US IVD Market Forecast by Value (2016-2021)
  • EMEA IVD Market Forecast by Value (2016-2021)
  • Europe Microbiology Market by Indications (2016)
  • Asia-Pacific IVD Market Forecast by Value (2016-2021)
  • China IVD Market Forecast by Value (2016-2021)
  • Japan IVD Market Forecast by Value (2016-2021)
  • Latin America IVD Market Forecast by Value (2016-2021)
  • Global Type 2 Diabetes Patients Volume (2016-2021)
  • Global New Cancer Patients Volume (2012-2016)
  • Global Healthcare Expenditure Per Capita (2012-2016)
  • Global GDP Per Capita (2012-2016)
  • Global Population above 64 Years (2012-2016)
  • Global IVD Market Share by Company (2016)
  • Global Immunochemistry Market Share by Company (2016)
  • Global Molecular Diagnostics Market Share by Company (2016)
  • Global POCT Market Share by Company (2016)
  • Siemens AG Revenue by Segment (2016)
  • Siemens AG Revenue and Net Income (2012-2016*)
  • Siemens R&D Expenditure (2014-2016*)
  • Roche Holding AG Sales by Segment (2016)
  • Roche Holding AG Sales and Net Income (2012-2016)
  • Roche Holding AG R&D Expenditure (2014-2016)
  • Number of Products in Pipeline by Segments (2016)
  • Abbott Laboratories Sales by Segment (2016)
  • Abbott Laboratories Net Sales and Net Earnings (2012-2016)
  • Abbott Laboratories R&D Expenditure (2014-2016)
  • Danaher Corp. Revenue by Segments (2016)
  • Danaher Corp. Revenue and Net Earnings (2012-2016)
  • Danaher Corp. R&D Expenditure (2014-2016)

List of Charts

  • Growing Cases and Prevalence of STDs in the US (2012-2016)
  • Revenue and Market Cap. Comparison by Companies (2016)
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Roche Holding AG
  • Siemens AG
  • MORE

In-vitro diagnostics (IVD) tests are defined as tests executed outside a patient’s body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. Purpose for doing the IVD test is to prevent, effectively cure and mitigate any kind of risk and for post-treatment intensive care diseases and infections. IVD products are precisely designed and produced for collecting samples derived from the human body and scrutinizing them outside the human body.

The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into various sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test.

There has been continuous surge in the patients suffering from chronic ailments such as cancer. Such disease requires regular diagnosing in order to keep a tab of disease progression and pathogenesis. Thus, rising cases of such diseases will push the demand for more in-vitro diagnostic devices especially in POC, Immunochemistry and molecular diagnostics segments. Further, rising incidence of infectious diseases such as several STDs (HIV, syphilis, gonorrhea and chlamydia), Hantavirus pulmonary syndrome, Lyme disease, and hemolytic uremic syndrome, zika virus and many more have promulgated the need for early and effective diagnosis. This has resulted in the increased demand for IVDs throughout the globe and has become one of the primary growth driver for this market.

The report "Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)" analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth.

Note: Product cover images may vary from those shown
5 of 6
  • Abbott Laboratories
  • Danaher Corporation
  • Roche Holding AG
  • Siemens AG
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll